The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.

Calls for Proposals

EDCTP opened new calls for research proposals under its second programme: diagnostic tools for poverty-related diseases; maximising the impact of EDCTP research; strategic projects with major cofunding; improved treatment; and clinical management of poverty-related diseases.

Read more

About us

EDCTP is a partnership between Europa and sub-Saharan Africa, a partnership between 14 African and 14 European countries that jointly contribute to the fight against HIV/Aids, tuberculosis, malaria and other neglected infectious diseases.

Find out more about who we are!

Read more

Scope

EDCTP2 aims to contribute to the reduction of the social and economic burden of poverty-related diseases (PRDs) in developing countries, in particular in sub-Saharan Africa, by accelerating the clinical development of effective, safe, accessible, suitable and affordable medical interventions for PRDs in partnership with sub-Saharan Africa.

Read more

Latest news

24 August 2015

European and African clinical research on poverty-related and neglected diseases, 2003-2011 - a bibliometric analysis

On 11 August 2015 PLOS neglected tropical diseases published the research article ‘Bibliometric assessment of European and sub-Saharan African research…

Read more
10 August 2015

EDCTP Annual Report 2014 available online

The online summary EDCTP Annual Report 2014 “Starting EDCTP2” is now available on the website. It offers an updated overview…

Read more